MindWalk Holdings (HYFT) EBT Margin (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly EBT Margin of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and up 99.98% quarter-over-quarter from 0.51% in Q1 2026.
MindWalk Holdings (HYFT) EBT Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBT Margin for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT Margin changed 0.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 35.2% (down 289.0% YoY), while the FY2026 annual figure was 99.96%, up 25418.0% from the prior year.
- EBT Margin grew to 0.0% in Q2 2026 per HYFT's latest filing, from 0.51% in the prior quarter.
- Across five years, EBT Margin topped out at 91395.13% in Q3 2025 and bottomed at 805.78% in Q2 2023.
- Historically, EBT Margin has averaged 11346.09% across 5 years, with a median of 33.96% in 2023.
- Annual changes were most pronounced in 2022 — EBT Margin surged 2000000000 bps — and 2024, when it plunged 8048516 bps.
- MindWalk Holdings' EBT Margin stood at 103.24% in 2022, then jumped by 30565 bps to 31658.54% in 2023, then slumped by 100 bps to 88.95% in 2024, then tumbled by 100 bps to 0.08% in 2025, then plunged by 100 bps to 0.0% in 2026.
- Business Quant data shows HYFT's EBT Margin at 0.0% in Q2 2026, 0.51% in Q1 2026, and 0.08% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.00% |
| Jan 31, 2026 | -0.51% |
| Oct 31, 2025 | 0.08% |
| Jul 31, 2025 | 91,395.13% |
| Apr 30, 2025 | 0.00% |
| Jan 31, 2025 | 771.63% |
| Oct 31, 2024 | 88.95% |
| Jul 31, 2024 | 140.72% |
| Apr 30, 2024 | 536.98% |
| Jan 31, 2024 | 49.53% |
| Oct 31, 2023 | 31,658.54% |
| Jul 31, 2023 | 80,625.88% |
| Apr 30, 2023 | -805.78% |
| Jan 31, 2023 | 18.39% |
| Oct 31, 2022 | 103.24% |
| Jul 31, 2022 | -0.24% |
| Apr 30, 2022 | -352.89% |
| Jan 31, 2022 | -0.08% |
| Oct 31, 2021 | -118.38% |
| Jul 31, 2021 | -72.89% |